nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisolone—CYP3A4—bone cancer	0.706	1	CbGaD
Prednisolone—SLCO1A2—Methotrexate—bone cancer	0.0515	0.469	CbGbCtD
Prednisolone—ABCB1—Cisplatin—bone cancer	0.0214	0.195	CbGbCtD
Prednisolone—ABCB1—Doxorubicin—bone cancer	0.0144	0.131	CbGbCtD
Prednisolone—ABCB1—Methotrexate—bone cancer	0.0139	0.127	CbGbCtD
Prednisolone—CYP3A4—Doxorubicin—bone cancer	0.00861	0.0784	CbGbCtD
Prednisolone—Aseptic necrosis—Methotrexate—bone cancer	0.00633	0.0404	CcSEcCtD
Prednisolone—Paraplegia—Methotrexate—bone cancer	0.00539	0.0344	CcSEcCtD
Prednisolone—Diplegia—Methotrexate—bone cancer	0.00503	0.0321	CcSEcCtD
Prednisolone—Glucose tolerance impaired—Cisplatin—bone cancer	0.00494	0.0315	CcSEcCtD
Prednisolone—Monoplegia—Methotrexate—bone cancer	0.00472	0.0301	CcSEcCtD
Prednisolone—Papilloedema—Cisplatin—bone cancer	0.00418	0.0267	CcSEcCtD
Prednisolone—Arachnoiditis—Methotrexate—bone cancer	0.004	0.0255	CcSEcCtD
Prednisolone—Optic neuritis—Cisplatin—bone cancer	0.00216	0.0138	CcSEcCtD
Prednisolone—Thromboembolism—Epirubicin—bone cancer	0.00215	0.0137	CcSEcCtD
Prednisolone—Thromboembolism—Doxorubicin—bone cancer	0.00199	0.0127	CcSEcCtD
Prednisolone—Osteonecrosis—Methotrexate—bone cancer	0.00196	0.0125	CcSEcCtD
Prednisolone—Cardiomegaly—Epirubicin—bone cancer	0.00187	0.0119	CcSEcCtD
Prednisolone—Cardiomegaly—Doxorubicin—bone cancer	0.00173	0.011	CcSEcCtD
Prednisolone—Leukoderma—Methotrexate—bone cancer	0.00172	0.0109	CcSEcCtD
Prednisolone—Impaired healing—Methotrexate—bone cancer	0.00169	0.0108	CcSEcCtD
Prednisolone—Abscess—Cisplatin—bone cancer	0.00168	0.0107	CcSEcCtD
Prednisolone—Leukoderma—Epirubicin—bone cancer	0.00161	0.0102	CcSEcCtD
Prednisolone—Leukoderma—Doxorubicin—bone cancer	0.00149	0.00947	CcSEcCtD
Prednisolone—Pain—Carboplatin—bone cancer	0.00138	0.00882	CcSEcCtD
Prednisolone—Embolism venous—Epirubicin—bone cancer	0.00135	0.00863	CcSEcCtD
Prednisolone—Hiccups—Cisplatin—bone cancer	0.00133	0.00848	CcSEcCtD
Prednisolone—Osteoporosis—Methotrexate—bone cancer	0.0013	0.0083	CcSEcCtD
Prednisolone—Hypernatraemia—Epirubicin—bone cancer	0.0013	0.00828	CcSEcCtD
Prednisolone—NR3C2—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00129	0.0655	CbGpPWpGaD
Prednisolone—NR3C1—Signaling events mediated by HDAC Class II—BCOR—bone cancer	0.00129	0.0653	CbGpPWpGaD
Prednisolone—Fluid retention—Cisplatin—bone cancer	0.00126	0.00805	CcSEcCtD
Prednisolone—Embolism venous—Doxorubicin—bone cancer	0.00125	0.00798	CcSEcCtD
Prednisolone—Neuropathy—Cisplatin—bone cancer	0.00125	0.00796	CcSEcCtD
Prednisolone—Hypernatraemia—Doxorubicin—bone cancer	0.0012	0.00766	CcSEcCtD
Prednisolone—Embolism—Methotrexate—bone cancer	0.00114	0.00725	CcSEcCtD
Prednisolone—Optic neuritis—Epirubicin—bone cancer	0.00111	0.00708	CcSEcCtD
Prednisolone—Cardiac failure congestive—Cisplatin—bone cancer	0.00106	0.00678	CcSEcCtD
Prednisolone—Embolism—Epirubicin—bone cancer	0.00106	0.00678	CcSEcCtD
Prednisolone—Keratitis—Epirubicin—bone cancer	0.00105	0.00671	CcSEcCtD
Prednisolone—CYP2A6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00105	0.0533	CbGpPWpGaD
Prednisolone—Optic neuritis—Doxorubicin—bone cancer	0.00103	0.00655	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Cisplatin—bone cancer	0.000998	0.00636	CcSEcCtD
Prednisolone—Embolism—Doxorubicin—bone cancer	0.000985	0.00627	CcSEcCtD
Prednisolone—Keratitis—Doxorubicin—bone cancer	0.000974	0.00621	CcSEcCtD
Prednisolone—Hepatomegaly—Epirubicin—bone cancer	0.000965	0.00615	CcSEcCtD
Prednisolone—Blister—Epirubicin—bone cancer	0.000948	0.00604	CcSEcCtD
Prednisolone—Dermatitis atopic—Epirubicin—bone cancer	0.000923	0.00588	CcSEcCtD
Prednisolone—Abscess—Methotrexate—bone cancer	0.000922	0.00588	CcSEcCtD
Prednisolone—Neuritis—Epirubicin—bone cancer	0.000915	0.00583	CcSEcCtD
Prednisolone—Hepatomegaly—Doxorubicin—bone cancer	0.000893	0.00569	CcSEcCtD
Prednisolone—Petechiae—Methotrexate—bone cancer	0.000887	0.00565	CcSEcCtD
Prednisolone—Blister—Doxorubicin—bone cancer	0.000877	0.00559	CcSEcCtD
Prednisolone—Abscess—Epirubicin—bone cancer	0.000863	0.0055	CcSEcCtD
Prednisolone—Dermatitis atopic—Doxorubicin—bone cancer	0.000854	0.00544	CcSEcCtD
Prednisolone—Neuritis—Doxorubicin—bone cancer	0.000847	0.00539	CcSEcCtD
Prednisolone—Stinging—Epirubicin—bone cancer	0.000843	0.00537	CcSEcCtD
Prednisolone—Petechiae—Epirubicin—bone cancer	0.00083	0.00529	CcSEcCtD
Prednisolone—Pancreatitis—Cisplatin—bone cancer	0.000818	0.00521	CcSEcCtD
Prednisolone—Sweating increased—Cisplatin—bone cancer	0.000813	0.00518	CcSEcCtD
Prednisolone—Abscess—Doxorubicin—bone cancer	0.000799	0.00509	CcSEcCtD
Prednisolone—Herpes simplex—Methotrexate—bone cancer	0.000792	0.00505	CcSEcCtD
Prednisolone—Stinging—Doxorubicin—bone cancer	0.00078	0.00497	CcSEcCtD
Prednisolone—Petechiae—Doxorubicin—bone cancer	0.000768	0.0049	CcSEcCtD
Prednisolone—Viral infection—Epirubicin—bone cancer	0.000756	0.00482	CcSEcCtD
Prednisolone—Arthropathy—Epirubicin—bone cancer	0.000751	0.00479	CcSEcCtD
Prednisolone—Vasculitis—Methotrexate—bone cancer	0.000748	0.00477	CcSEcCtD
Prednisolone—Exemestane—CYP3A4—bone cancer	0.000744	0.0978	CrCbGaD
Prednisolone—Herpes simplex—Epirubicin—bone cancer	0.000741	0.00472	CcSEcCtD
Prednisolone—Acute coronary syndrome—Cisplatin—bone cancer	0.000733	0.00467	CcSEcCtD
Prednisolone—Myocardial infarction—Cisplatin—bone cancer	0.000729	0.00465	CcSEcCtD
Prednisolone—Neuropathy peripheral—Cisplatin—bone cancer	0.000729	0.00465	CcSEcCtD
Prednisolone—Conjunctivitis—Cisplatin—bone cancer	0.000723	0.00461	CcSEcCtD
Prednisolone—Viral infection—Doxorubicin—bone cancer	0.0007	0.00446	CcSEcCtD
Prednisolone—Arthropathy—Doxorubicin—bone cancer	0.000695	0.00443	CcSEcCtD
Prednisolone—Herpes simplex—Doxorubicin—bone cancer	0.000686	0.00437	CcSEcCtD
Prednisolone—Hiccups—Epirubicin—bone cancer	0.000683	0.00435	CcSEcCtD
Prednisolone—Bradycardia—Cisplatin—bone cancer	0.00068	0.00433	CcSEcCtD
Prednisolone—Ecchymosis—Methotrexate—bone cancer	0.00066	0.00421	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—ZNF77—bone cancer	0.00066	0.0334	CbGpPWpGaD
Prednisolone—Pulmonary oedema—Methotrexate—bone cancer	0.00065	0.00414	CcSEcCtD
Prednisolone—Fluid retention—Epirubicin—bone cancer	0.000648	0.00413	CcSEcCtD
Prednisolone—Visual impairment—Cisplatin—bone cancer	0.000644	0.0041	CcSEcCtD
Prednisolone—Neuropathy—Epirubicin—bone cancer	0.000641	0.00409	CcSEcCtD
Prednisolone—Hiccups—Doxorubicin—bone cancer	0.000632	0.00403	CcSEcCtD
Prednisolone—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000629	0.0319	CbGpPWpGaD
Prednisolone—Ecchymosis—Epirubicin—bone cancer	0.000618	0.00394	CcSEcCtD
Prednisolone—Thrombophlebitis—Methotrexate—bone cancer	0.000612	0.0039	CcSEcCtD
Prednisolone—NR3C1—Signaling events mediated by HDAC Class II—TUBB2A—bone cancer	0.00061	0.0309	CbGpPWpGaD
Prednisolone—Diabetes mellitus—Methotrexate—bone cancer	0.000609	0.00388	CcSEcCtD
Prednisolone—Pulmonary oedema—Epirubicin—bone cancer	0.000608	0.00387	CcSEcCtD
Prednisolone—CYP2A6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000607	0.0308	CbGpPWpGaD
Prednisolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—bone cancer	0.000601	0.0304	CbGpPWpGaD
Prednisolone—Fluid retention—Doxorubicin—bone cancer	0.0006	0.00382	CcSEcCtD
Prednisolone—Arrhythmia—Cisplatin—bone cancer	0.000597	0.0038	CcSEcCtD
Prednisolone—Neuropathy—Doxorubicin—bone cancer	0.000593	0.00378	CcSEcCtD
Prednisolone—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000589	0.0298	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000588	0.0298	CbGpPWpGaD
Prednisolone—Erythema—Cisplatin—bone cancer	0.000581	0.00371	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptors—NR1I2—bone cancer	0.000576	0.0292	CbGpPWpGaD
Prednisolone—Thrombophlebitis—Epirubicin—bone cancer	0.000573	0.00365	CcSEcCtD
Prednisolone—Ecchymosis—Doxorubicin—bone cancer	0.000571	0.00364	CcSEcCtD
Prednisolone—Diabetes mellitus—Epirubicin—bone cancer	0.00057	0.00363	CcSEcCtD
Prednisolone—Pulmonary oedema—Doxorubicin—bone cancer	0.000563	0.00359	CcSEcCtD
Prednisolone—Visual disturbance—Methotrexate—bone cancer	0.000559	0.00356	CcSEcCtD
Prednisolone—Hydrocortamate—CYP3A4—bone cancer	0.000555	0.0729	CrCbGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—FEV—bone cancer	0.00055	0.0279	CbGpPWpGaD
Prednisolone—Vision blurred—Cisplatin—bone cancer	0.000548	0.00349	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Methotrexate—bone cancer	0.000547	0.00349	CcSEcCtD
Prednisolone—Cardiac failure congestive—Epirubicin—bone cancer	0.000547	0.00348	CcSEcCtD
Prednisolone—Cortisone acetate—CYP3A4—bone cancer	0.000546	0.0718	CrCbGaD
Prednisolone—Ill-defined disorder—Cisplatin—bone cancer	0.000539	0.00344	CcSEcCtD
Prednisolone—Thrombophlebitis—Doxorubicin—bone cancer	0.00053	0.00338	CcSEcCtD
Prednisolone—Osteoarthritis—Methotrexate—bone cancer	0.00053	0.00338	CcSEcCtD
Prednisolone—Increased appetite—Epirubicin—bone cancer	0.000528	0.00336	CcSEcCtD
Prednisolone—Diabetes mellitus—Doxorubicin—bone cancer	0.000527	0.00336	CcSEcCtD
Prednisolone—Malaise—Cisplatin—bone cancer	0.000524	0.00334	CcSEcCtD
Prednisolone—Dermatitis bullous—Epirubicin—bone cancer	0.000519	0.00331	CcSEcCtD
Prednisolone—Budesonide—CYP3A4—bone cancer	0.000516	0.0678	CrCbGaD
Prednisolone—Anaphylactoid reaction—Epirubicin—bone cancer	0.000512	0.00326	CcSEcCtD
Prednisolone—CYP2A6—Xenobiotics—CYP3A4—bone cancer	0.000507	0.0257	CbGpPWpGaD
Prednisolone—Cardiac failure congestive—Doxorubicin—bone cancer	0.000506	0.00322	CcSEcCtD
Prednisolone—Convulsion—Cisplatin—bone cancer	0.000504	0.00321	CcSEcCtD
Prednisolone—Mood swings—Methotrexate—bone cancer	0.000502	0.0032	CcSEcCtD
Prednisolone—Osteoarthritis—Epirubicin—bone cancer	0.000496	0.00316	CcSEcCtD
Prednisolone—Discomfort—Cisplatin—bone cancer	0.000489	0.00312	CcSEcCtD
Prednisolone—Increased appetite—Doxorubicin—bone cancer	0.000488	0.00311	CcSEcCtD
Prednisolone—Affect lability—Epirubicin—bone cancer	0.000488	0.00311	CcSEcCtD
Prednisolone—CYP2A6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000488	0.0247	CbGpPWpGaD
Prednisolone—Dermatitis bullous—Doxorubicin—bone cancer	0.00048	0.00306	CcSEcCtD
Prednisolone—Anaphylactic shock—Cisplatin—bone cancer	0.000475	0.00302	CcSEcCtD
Prednisolone—Oedema—Cisplatin—bone cancer	0.000475	0.00302	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000474	0.00302	CcSEcCtD
Prednisolone—Cardiac arrest—Epirubicin—bone cancer	0.000471	0.003	CcSEcCtD
Prednisolone—Mood swings—Epirubicin—bone cancer	0.00047	0.00299	CcSEcCtD
Prednisolone—Tachycardia—Cisplatin—bone cancer	0.000463	0.00295	CcSEcCtD
Prednisolone—Osteoarthritis—Doxorubicin—bone cancer	0.000459	0.00292	CcSEcCtD
Prednisolone—Hyperhidrosis—Cisplatin—bone cancer	0.000459	0.00292	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.000455	0.0231	CbGpPWpGaD
Prednisolone—Dry skin—Epirubicin—bone cancer	0.000454	0.0029	CcSEcCtD
Prednisolone—Affect lability—Doxorubicin—bone cancer	0.000452	0.00288	CcSEcCtD
Prednisolone—Pancreatitis—Methotrexate—bone cancer	0.000449	0.00286	CcSEcCtD
Prednisolone—Alclometasone—CYP3A4—bone cancer	0.000445	0.0584	CrCbGaD
Prednisolone—Muscular weakness—Epirubicin—bone cancer	0.000437	0.00279	CcSEcCtD
Prednisolone—Cardiac arrest—Doxorubicin—bone cancer	0.000436	0.00278	CcSEcCtD
Prednisolone—Mood swings—Doxorubicin—bone cancer	0.000435	0.00277	CcSEcCtD
Prednisolone—Flunisolide—CYP3A4—bone cancer	0.000433	0.0569	CrCbGaD
Prednisolone—Abdominal distension—Epirubicin—bone cancer	0.000431	0.00275	CcSEcCtD
Prednisolone—Paramethasone—CYP3A4—bone cancer	0.000427	0.0562	CrCbGaD
Prednisolone—Paraesthesia—Cisplatin—bone cancer	0.000426	0.00272	CcSEcCtD
Prednisolone—Ciclesonide—CYP3A4—bone cancer	0.000421	0.0553	CrCbGaD
Prednisolone—Dry skin—Doxorubicin—bone cancer	0.000421	0.00268	CcSEcCtD
Prednisolone—Pancreatitis—Epirubicin—bone cancer	0.00042	0.00268	CcSEcCtD
Prednisolone—Fluorometholone—CYP3A4—bone cancer	0.000417	0.0548	CrCbGaD
Prednisolone—Pain—Cisplatin—bone cancer	0.000406	0.00259	CcSEcCtD
Prednisolone—Muscular weakness—Doxorubicin—bone cancer	0.000405	0.00258	CcSEcCtD
Prednisolone—Methylprednisolone—CYP3A4—bone cancer	0.000403	0.053	CrCbGaD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—DHFR—bone cancer	0.000401	0.0203	CbGpPWpGaD
Prednisolone—Abdominal distension—Doxorubicin—bone cancer	0.000399	0.00254	CcSEcCtD
Prednisolone—Conjunctivitis—Methotrexate—bone cancer	0.000397	0.00253	CcSEcCtD
Prednisolone—Feeling abnormal—Cisplatin—bone cancer	0.000391	0.00249	CcSEcCtD
Prednisolone—Weight increased—Epirubicin—bone cancer	0.00039	0.00249	CcSEcCtD
Prednisolone—Pancreatitis—Doxorubicin—bone cancer	0.000389	0.00248	CcSEcCtD
Prednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000386	0.0195	CbGpPWpGaD
Prednisolone—Neuropathy peripheral—Epirubicin—bone cancer	0.000375	0.00239	CcSEcCtD
Prednisolone—Conjunctivitis—Epirubicin—bone cancer	0.000371	0.00237	CcSEcCtD
Prednisolone—Haemoglobin—Methotrexate—bone cancer	0.000368	0.00235	CcSEcCtD
Prednisolone—Haemorrhage—Methotrexate—bone cancer	0.000367	0.00234	CcSEcCtD
Prednisolone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000363	0.0184	CbGpPWpGaD
Prednisolone—Weight increased—Doxorubicin—bone cancer	0.000361	0.0023	CcSEcCtD
Prednisolone—Visual impairment—Methotrexate—bone cancer	0.000353	0.00225	CcSEcCtD
Prednisolone—Hypersensitivity—Cisplatin—bone cancer	0.00035	0.00223	CcSEcCtD
Prednisolone—Bradycardia—Epirubicin—bone cancer	0.000349	0.00223	CcSEcCtD
Prednisolone—CYP2A6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000348	0.0177	CbGpPWpGaD
Prednisolone—Neuropathy peripheral—Doxorubicin—bone cancer	0.000347	0.00221	CcSEcCtD
Prednisolone—Haemoglobin—Epirubicin—bone cancer	0.000345	0.0022	CcSEcCtD
Prednisolone—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000344	0.0174	CbGpPWpGaD
Prednisolone—Conjunctivitis—Doxorubicin—bone cancer	0.000344	0.00219	CcSEcCtD
Prednisolone—Haemorrhage—Epirubicin—bone cancer	0.000343	0.00219	CcSEcCtD
Prednisolone—Triamcinolone—CYP3A4—bone cancer	0.00034	0.0447	CrCbGaD
Prednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000338	0.0171	CbGpPWpGaD
Prednisolone—Triamcinolone—PTGS2—bone cancer	0.000333	0.0438	CrCbGaD
Prednisolone—Visual impairment—Epirubicin—bone cancer	0.000331	0.00211	CcSEcCtD
Prednisolone—Bradycardia—Doxorubicin—bone cancer	0.000323	0.00206	CcSEcCtD
Prednisolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—bone cancer	0.000321	0.0163	CbGpPWpGaD
Prednisolone—Erythema—Methotrexate—bone cancer	0.000319	0.00203	CcSEcCtD
Prednisolone—Haemoglobin—Doxorubicin—bone cancer	0.000319	0.00203	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—ZNF77—bone cancer	0.000318	0.0161	CbGpPWpGaD
Prednisolone—Haemorrhage—Doxorubicin—bone cancer	0.000317	0.00202	CcSEcCtD
Prednisolone—Prednisone—CYP3A4—bone cancer	0.000309	0.0405	CrCbGaD
Prednisolone—Arrhythmia—Epirubicin—bone cancer	0.000306	0.00195	CcSEcCtD
Prednisolone—Visual impairment—Doxorubicin—bone cancer	0.000306	0.00195	CcSEcCtD
Prednisolone—Vision blurred—Methotrexate—bone cancer	0.000301	0.00192	CcSEcCtD
Prednisolone—Rash—Cisplatin—bone cancer	0.000299	0.00191	CcSEcCtD
Prednisolone—Dermatitis—Cisplatin—bone cancer	0.000299	0.00191	CcSEcCtD
Prednisolone—Erythema—Epirubicin—bone cancer	0.000299	0.0019	CcSEcCtD
Prednisolone—Ill-defined disorder—Methotrexate—bone cancer	0.000296	0.00189	CcSEcCtD
Prednisolone—Methyltestosterone—CYP3A4—bone cancer	0.000289	0.0379	CrCbGaD
Prednisolone—Malaise—Methotrexate—bone cancer	0.000288	0.00183	CcSEcCtD
Prednisolone—Vertigo—Methotrexate—bone cancer	0.000287	0.00183	CcSEcCtD
Prednisolone—Arrhythmia—Doxorubicin—bone cancer	0.000284	0.00181	CcSEcCtD
Prednisolone—Nausea—Cisplatin—bone cancer	0.000282	0.0018	CcSEcCtD
Prednisolone—Vision blurred—Epirubicin—bone cancer	0.000281	0.00179	CcSEcCtD
Prednisolone—Betamethasone—CYP3A4—bone cancer	0.000279	0.0366	CrCbGaD
Prednisolone—Ill-defined disorder—Epirubicin—bone cancer	0.000277	0.00177	CcSEcCtD
Prednisolone—Convulsion—Methotrexate—bone cancer	0.000276	0.00176	CcSEcCtD
Prednisolone—Erythema—Doxorubicin—bone cancer	0.000276	0.00176	CcSEcCtD
Prednisolone—Betamethasone—PTGS2—bone cancer	0.000273	0.0358	CrCbGaD
Prednisolone—Malaise—Epirubicin—bone cancer	0.000269	0.00172	CcSEcCtD
Prednisolone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—bone cancer	0.000269	0.0136	CbGpPWpGaD
Prednisolone—Discomfort—Methotrexate—bone cancer	0.000268	0.00171	CcSEcCtD
Prednisolone—Vertigo—Epirubicin—bone cancer	0.000268	0.00171	CcSEcCtD
Prednisolone—Syncope—Epirubicin—bone cancer	0.000268	0.00171	CcSEcCtD
Prednisolone—Loss of consciousness—Epirubicin—bone cancer	0.000262	0.00167	CcSEcCtD
Prednisolone—Anaphylactic shock—Methotrexate—bone cancer	0.00026	0.00166	CcSEcCtD
Prednisolone—Vision blurred—Doxorubicin—bone cancer	0.00026	0.00166	CcSEcCtD
Prednisolone—Convulsion—Epirubicin—bone cancer	0.000259	0.00165	CcSEcCtD
Prednisolone—Hypertension—Epirubicin—bone cancer	0.000258	0.00164	CcSEcCtD
Prednisolone—Ill-defined disorder—Doxorubicin—bone cancer	0.000256	0.00163	CcSEcCtD
Prednisolone—Hyperhidrosis—Methotrexate—bone cancer	0.000252	0.0016	CcSEcCtD
Prednisolone—Discomfort—Epirubicin—bone cancer	0.000251	0.0016	CcSEcCtD
Prednisolone—Malaise—Doxorubicin—bone cancer	0.000249	0.00159	CcSEcCtD
Prednisolone—Vertigo—Doxorubicin—bone cancer	0.000248	0.00158	CcSEcCtD
Prednisolone—Syncope—Doxorubicin—bone cancer	0.000248	0.00158	CcSEcCtD
Prednisolone—Anaphylactic shock—Epirubicin—bone cancer	0.000244	0.00155	CcSEcCtD
Prednisolone—Oedema—Epirubicin—bone cancer	0.000244	0.00155	CcSEcCtD
Prednisolone—Loss of consciousness—Doxorubicin—bone cancer	0.000243	0.00155	CcSEcCtD
Prednisolone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.000242	0.0123	CbGpPWpGaD
Prednisolone—Shock—Epirubicin—bone cancer	0.00024	0.00153	CcSEcCtD
Prednisolone—Convulsion—Doxorubicin—bone cancer	0.000239	0.00153	CcSEcCtD
Prednisolone—Hypertension—Doxorubicin—bone cancer	0.000239	0.00152	CcSEcCtD
Prednisolone—Tachycardia—Epirubicin—bone cancer	0.000238	0.00152	CcSEcCtD
Prednisolone—Hyperhidrosis—Epirubicin—bone cancer	0.000236	0.0015	CcSEcCtD
Prednisolone—Insomnia—Methotrexate—bone cancer	0.000236	0.0015	CcSEcCtD
Prednisolone—Paraesthesia—Methotrexate—bone cancer	0.000234	0.00149	CcSEcCtD
Prednisolone—Discomfort—Doxorubicin—bone cancer	0.000232	0.00148	CcSEcCtD
Prednisolone—NR3C1—Generic Transcription Pathway—ZNF77—bone cancer	0.000232	0.0118	CbGpPWpGaD
Prednisolone—NR3C1—Endoderm Differentiation—EZH2—bone cancer	0.000232	0.0118	CbGpPWpGaD
Prednisolone—Anaphylactic shock—Doxorubicin—bone cancer	0.000225	0.00144	CcSEcCtD
Prednisolone—Oedema—Doxorubicin—bone cancer	0.000225	0.00144	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—NR1I2—bone cancer	0.000223	0.0113	CbGpPWpGaD
Prednisolone—Pain—Methotrexate—bone cancer	0.000223	0.00142	CcSEcCtD
Prednisolone—Shock—Doxorubicin—bone cancer	0.000222	0.00141	CcSEcCtD
Prednisolone—Insomnia—Epirubicin—bone cancer	0.00022	0.0014	CcSEcCtD
Prednisolone—Tachycardia—Doxorubicin—bone cancer	0.00022	0.0014	CcSEcCtD
Prednisolone—Paraesthesia—Epirubicin—bone cancer	0.000219	0.00139	CcSEcCtD
Prednisolone—Hyperhidrosis—Doxorubicin—bone cancer	0.000218	0.00139	CcSEcCtD
Prednisolone—Hydrocortisone—CYP3A4—bone cancer	0.000217	0.0286	CrCbGaD
Prednisolone—Feeling abnormal—Methotrexate—bone cancer	0.000215	0.00137	CcSEcCtD
Prednisolone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000211	0.0107	CbGpPWpGaD
Prednisolone—Pain—Epirubicin—bone cancer	0.000208	0.00133	CcSEcCtD
Prednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000208	0.0106	CbGpPWpGaD
Prednisolone—CYP2A6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000208	0.0105	CbGpPWpGaD
Prednisolone—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000207	0.0105	CbGpPWpGaD
Prednisolone—Urticaria—Methotrexate—bone cancer	0.000207	0.00132	CcSEcCtD
Prednisolone—Insomnia—Doxorubicin—bone cancer	0.000204	0.0013	CcSEcCtD
Prednisolone—Paraesthesia—Doxorubicin—bone cancer	0.000202	0.00129	CcSEcCtD
Prednisolone—Feeling abnormal—Epirubicin—bone cancer	0.000201	0.00128	CcSEcCtD
Prednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000198	0.01	CbGpPWpGaD
Prednisolone—Urticaria—Epirubicin—bone cancer	0.000194	0.00123	CcSEcCtD
Prednisolone—Pain—Doxorubicin—bone cancer	0.000193	0.00123	CcSEcCtD
Prednisolone—Hypersensitivity—Methotrexate—bone cancer	0.000192	0.00122	CcSEcCtD
Prednisolone—Feeling abnormal—Doxorubicin—bone cancer	0.000186	0.00118	CcSEcCtD
Prednisolone—Hypersensitivity—Epirubicin—bone cancer	0.00018	0.00114	CcSEcCtD
Prednisolone—Urticaria—Doxorubicin—bone cancer	0.000179	0.00114	CcSEcCtD
Prednisolone—Progesterone—CYP3A4—bone cancer	0.000177	0.0233	CrCbGaD
Prednisolone—Dizziness—Methotrexate—bone cancer	0.000172	0.0011	CcSEcCtD
Prednisolone—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000171	0.00866	CbGpPWpGaD
Prednisolone—Testosterone—CYP3A4—bone cancer	0.000167	0.022	CrCbGaD
Prednisolone—Hypersensitivity—Doxorubicin—bone cancer	0.000166	0.00106	CcSEcCtD
Prednisolone—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000166	0.00841	CbGpPWpGaD
Prednisolone—Rash—Methotrexate—bone cancer	0.000164	0.00105	CcSEcCtD
Prednisolone—Dermatitis—Methotrexate—bone cancer	0.000164	0.00105	CcSEcCtD
Prednisolone—Headache—Methotrexate—bone cancer	0.000163	0.00104	CcSEcCtD
Prednisolone—Dexamethasone—CYP3A4—bone cancer	0.000162	0.0213	CrCbGaD
Prednisolone—Dizziness—Epirubicin—bone cancer	0.000161	0.00103	CcSEcCtD
Prednisolone—Dexamethasone—PTGS2—bone cancer	0.000159	0.0208	CrCbGaD
Prednisolone—NR3C2—Gene Expression—FUS—bone cancer	0.000155	0.00786	CbGpPWpGaD
Prednisolone—Nausea—Methotrexate—bone cancer	0.000155	0.000986	CcSEcCtD
Prednisolone—Rash—Epirubicin—bone cancer	0.000154	0.000979	CcSEcCtD
Prednisolone—Dermatitis—Epirubicin—bone cancer	0.000154	0.000978	CcSEcCtD
Prednisolone—Headache—Epirubicin—bone cancer	0.000153	0.000973	CcSEcCtD
Prednisolone—Dizziness—Doxorubicin—bone cancer	0.000149	0.00095	CcSEcCtD
Prednisolone—Nausea—Epirubicin—bone cancer	0.000145	0.000922	CcSEcCtD
Prednisolone—Rash—Doxorubicin—bone cancer	0.000142	0.000906	CcSEcCtD
Prednisolone—Dermatitis—Doxorubicin—bone cancer	0.000142	0.000905	CcSEcCtD
Prednisolone—Headache—Doxorubicin—bone cancer	0.000141	0.0009	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—PLAU—bone cancer	0.000135	0.00686	CbGpPWpGaD
Prednisolone—Nausea—Doxorubicin—bone cancer	0.000134	0.000854	CcSEcCtD
Prednisolone—NR3C1—Regulation of Androgen receptor activity—MDM2—bone cancer	0.000118	0.00601	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000114	0.00577	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—ZNF77—bone cancer	0.000112	0.00567	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—NR1I2—bone cancer	0.000107	0.00545	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of Androgen receptor activity—JUN—bone cancer	0.000103	0.00522	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.67e-05	0.0049	CbGpPWpGaD
Prednisolone—CYP2A6—Biological oxidations—CYP3A4—bone cancer	9.07e-05	0.0046	CbGpPWpGaD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	8.96e-05	0.00454	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	8.85e-05	0.00449	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—GSTP1—bone cancer	8.85e-05	0.00449	CbGpPWpGaD
Prednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	8.6e-05	0.00436	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—bone cancer	8.36e-05	0.00424	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.35e-05	0.00423	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—JUN—bone cancer	8.24e-05	0.00418	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—MMP9—bone cancer	8.02e-05	0.00407	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—EIF2S1—bone cancer	7.94e-05	0.00402	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—NR1I2—bone cancer	7.86e-05	0.00398	CbGpPWpGaD
Prednisolone—CYP2A6—Biological oxidations—GSTP1—bone cancer	7.76e-05	0.00393	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—NDUFA12—bone cancer	7.56e-05	0.00383	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	7.33e-05	0.00372	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—JUN—bone cancer	7.26e-05	0.00368	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	7.04e-05	0.00357	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—EZH2—bone cancer	6.9e-05	0.0035	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—RB1—bone cancer	6.78e-05	0.00344	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—NT5C3A—bone cancer	6.26e-05	0.00318	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	5.99e-05	0.00304	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—FUS—bone cancer	5.46e-05	0.00277	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	5.45e-05	0.00276	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—TP53—bone cancer	5.44e-05	0.00276	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—NDUFA12—bone cancer	5.44e-05	0.00276	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	4.97e-05	0.00252	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	4.9e-05	0.00248	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—bone cancer	4.79e-05	0.00243	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	4.64e-05	0.00235	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—NT5C3A—bone cancer	4.51e-05	0.00228	CbGpPWpGaD
Prednisolone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	4.39e-05	0.00223	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—JUN—bone cancer	4.34e-05	0.0022	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	4.15e-05	0.0021	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.14e-05	0.0021	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NR1I2—bone cancer	3.78e-05	0.00192	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.57e-05	0.00181	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—NDUFA12—bone cancer	3.24e-05	0.00164	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.08e-05	0.00156	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.85e-05	0.00144	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.81e-05	0.00142	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—EIF2S1—bone cancer	2.79e-05	0.00142	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ENO2—bone cancer	2.74e-05	0.00139	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—NT5C3A—bone cancer	2.68e-05	0.00136	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—DHFR—bone cancer	2.55e-05	0.00129	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—EZH2—bone cancer	2.43e-05	0.00123	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GNA11—bone cancer	2.38e-05	0.00121	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.28e-05	0.00116	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.2e-05	0.00112	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYP3A4—bone cancer	2.16e-05	0.00109	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.15e-05	0.00109	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—NDUFA12—bone cancer	1.99e-05	0.00101	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.98e-05	0.00101	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ENO2—bone cancer	1.97e-05	0.001	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GSTP1—bone cancer	1.84e-05	0.000935	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—DHFR—bone cancer	1.83e-05	0.000928	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GNA11—bone cancer	1.71e-05	0.000868	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—NT5C3A—bone cancer	1.65e-05	0.000838	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.56e-05	0.000791	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CYP3A4—bone cancer	1.55e-05	0.000787	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GSTP1—bone cancer	1.33e-05	0.000673	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.31e-05	0.000664	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ENO2—bone cancer	1.17e-05	0.000596	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—DHFR—bone cancer	1.09e-05	0.000552	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GNA11—bone cancer	1.02e-05	0.000516	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PTGS2—bone cancer	9.56e-06	0.000485	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYP3A4—bone cancer	9.23e-06	0.000468	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GSTP1—bone cancer	7.9e-06	0.0004	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ENO2—bone cancer	7.24e-06	0.000367	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PTGS2—bone cancer	6.88e-06	0.000349	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—DHFR—bone cancer	6.71e-06	0.00034	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GNA11—bone cancer	6.28e-06	0.000318	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GSTP1—bone cancer	4.87e-06	0.000247	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PTGS2—bone cancer	4.09e-06	0.000207	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PTGS2—bone cancer	2.52e-06	0.000128	CbGpPWpGaD
